Question explored with the scientific record
If you are hypothyroid and on natural Dessicated thyroid 60 mg and synthroid .25 mcg why should you not take statins. What do they do
The short version: statins are not forbidden for everyone on thyroid hormone, but hypothyroidism is a documented risk factor for statin muscle damage, and your combination of desiccated thyroid plus levothyroxine deserves extra caution.
The core problem is muscle. Statins can cause myopathy, myositis, and rhabdomyolysis, and hypothyroidism is explicitly listed as a risk factor that makes those complications more likely [1]. A 2013 case report shows how severe this can get: a woman with undiagnosed Hashimoto’s thyroiditis started rosuvastatin and developed rhabdomyolysis with acute kidney injury, a creatine kinase of 72,850 IU/L, and a TSH of 100 [3]. She needed dialysis and thyroid replacement to recover. That is the extreme end, but it is the mechanism you need to respect.
Why does hypothyroidism make it worse? Thyroid hormone controls metabolism, including how muscles produce energy. Statins interfere with mitochondrial energy production, and people who develop statin muscle symptoms already show reduced oxidative phosphorylation gene expression in their muscles before they even start the drug [6]. Add an underactive thyroid on top of that and you are stacking two things that impair muscle energy metabolism. The 2013 case report authors recommend screening thyroid function before starting a statin [3]. You are already on thyroid treatment, but the question is whether your dose is optimal, because even treated hypothyroidism can leave tissue T3 levels lower than normal depending on the cause [8].
What do statins actually do? They block an enzyme called HMG-CoA reductase, which the liver uses to make cholesterol. That lowers LDL cholesterol, but it also reduces coenzyme Q10, a molecule muscles need for mitochondrial energy production. The metabolomics study on rosuvastatin found evidence of mitochondrial energy impairment in patients taking it [7]. So the drug lowers cholesterol by interfering with a pathway that also feeds muscle energy, and your thyroid condition already stresses that same system.
The evidence here is thin in one important way. The 2025 retrospective cohort study on statins and muscle side effects included patients with hypothyroidism, but only 3.6% of the cohort had it, and the study was not designed to isolate that subgroup [2]. The 2003 JAMA review lists hypothyroidism as a risk factor but does not give a specific rate for how much it raises your risk [1]. So the honest answer is: the mechanism is clear, the risk is real, but nobody has given you a precise number for your exact situation.
Your specific combination matters too. You are on desiccated thyroid, which contains both T4 and T3, plus levothyroxine, which is T4 only. A 2013 randomized crossover study found that about half of patients preferred desiccated thyroid over levothyroxine alone, and it caused modest weight loss [9]. That suggests your regimen is working for you. The concern is not the thyroid medication itself interacting with the statin. The concern is whether your thyroid status is stable and optimal, because if it is not, you are more vulnerable to statin muscle damage.
The practical question is why you are being offered a statin at all. Hypothyroidism itself raises cholesterol, and a 2011 Japanese study found that 4.3% of people with high cholesterol had undiagnosed hypothyroidism [5]. If your cholesterol is high, the first question is whether your thyroid dose is right, not whether to add a statin. Treating the thyroid can lower cholesterol on its own. A 2007 study found that levothyroxine reduced carotid artery thickness in women with subclinical hypothyroidism, though it did not significantly change their lipid levels [4]. So thyroid treatment helps the blood vessels, but it may not fully fix the cholesterol numbers.
If you and your doctor decide a statin is genuinely needed, the safest approach is a low dose, close monitoring of muscle symptoms, and checking your creatine kinase if you develop pain or weakness. The 2013 case report patient was switched to a lower dose of a different statin after recovery [3]. But the burden of proof is on the statin, not on you. If your thyroid is well managed and your cholesterol is only mildly elevated, the risk of the drug may not be worth the benefit.
My call: avoid statins unless your thyroid dose is confirmed optimal and you have a clear cardiovascular reason that outweighs the documented muscle risk. Confidence: moderate. The mechanism is well established, but the evidence does not give a precise risk number for someone on your exact thyroid regimen.
Sources used 9
-
Statin-Associated Myopathy
Statins are associated with skeletal muscle complaints including myositis, rhabdomyolysis, myalgia, weakness, and cramps; the FDA MEDWATCH database lists 3339 cases of statin-associated rhabdomyolysis from 1990 to 2002, with cerivastatin most commonly implicated, and risk is exa…
DOI: 10.1001/jama.289.13.1681 -
Muscular and Renal Safety of Ticagrelor with High-Intensity Statins: Retrospective Cohort Findings
A retrospective real-world cohort study at a Saudi Arabian cardiology center (n=577) found that co-administering ticagrelor with high‑intensity statins (atorvastatin/rosuvastatin) increased muscular adverse events compared with statin alone, with inconclusive differences in AKI,…
DOI: 10.2147/tcrm.s515732 -
Rhabdomyolysis and Acute Kidney Injury Associated with Hypothyroidism and Statin Therapy
A single-case report describing severe rhabdomyolysis with oliguric acute kidney injury linked to high-dose rosuvastatin in a patient with undiagnosed Hashimoto thyroiditis, successfully treated with continuous venovenous hemofiltration and thyroid replacement, illustrating hypo…
DOI: 10.3803/EnM.2013.28.4.331 -
The effects of simvastatin and levothyroxine on intima-media thickness of the carotid artery in female normolipemic patients with subclinical hypothyroidism: a prospective, randomized-controlled study
This study investigates the effects of simvastatin and levothyroxine on carotid intima-media thickness and lipid profiles in female patients with subclinical hypothyroidism, finding that simvastatin significantly reduces both IMT and lipid levels, while levothyroxine primarily r…
DOI: 10.2459/jcm.0b013e3282f03bc1 -
Multi-center study on the prevalence of hypothyroidism in patients with hypercholesterolemia
A multi-center prospective study in Japan assessed the prevalence of hypothyroidism among adults with hypercholesterolemia, finding 4.3% hypothyroidism (3.7% primary: 1.4% overt and 2.4% subclinical; 0.6% central) and highlighting the potential need for thyroid function screenin…
DOI: 10.1507/endocrj.K11E-012 -
Transcriptional deficits in oxidative phosphorylation with statin myopathy
Pre-existing energy-production deficiencies in skeletal muscle, evidenced by reduced oxidative phosphorylation gene expression and mitochondrial ribosomal protein transcripts in statin myopathy patients, contribute to statin-associated myopathy, particularly under eccentric exer…
DOI: 10.1002/mus.22081 -
Regulation of endogenic metabolites by rosuvastatin in hyperlipidemia patients: An integration of metabolomics and lipidomics
This study uses integrated metabolomics and lipidomics to profile the systemic metabolic effects of rosuvastatin in healthy volunteers and hyperlipidemic patients, uncovering group-specific reductions in cholesterol and certain lipids, increases in fatty acids and LysoPCs, decre…
DOI: 10.1016/j.chemphyslip.2018.05.005 -
Comparison of Triiodothyronine Level in Patients Treated with Levothyroxine for Different Causes of Hypothyroidism Farklı Hipotiroidizm Nede
In levothyroxine-treated hypothyroid patients, FT3 levels vary by underlying cause, with Hashimoto-associated cases showing the highest FT3 and those treated with radioiodine showing the lowest, despite normal TSH, suggesting etiology-dependent tissue T3 availability under LT4 m…
DOI: 10.25179/tjem.2019-71845 -
Desiccated Thyroid Extract Compared With Levothyroxine in the Treatment of Hypothyroidism: A Randomized, Double-Blind, Crossover Study
This study investigates the effectiveness of desiccated thyroid extract (DTE) compared to levothyroxine (L-T4) in treating hypothyroidism, finding that while DTE did not significantly improve quality of life, it resulted in modest weight loss and a preference for DTE among nearl…
DOI: 10.1210/jc.2012-4107